Related references
Note: Only part of the references are listed.Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial
Hann-Chorng Kuo et al.
NEUROUROLOGY AND URODYNAMICS (2016)
Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey
Yuliang Wang et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2015)
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment
Philip M. Hanno et al.
JOURNAL OF UROLOGY (2015)
The long journey of botulinum neurotoxins into the synapse
Andreas Rummel
TOXICON (2015)
Botulinum Toxin for Neuropathic Pain: A Review of the Literature
Hyun-Mi Oh et al.
TOXINS (2015)
Targets for Botulinum Toxin in the Lower Urinary Tract
Francisco Cruz
NEUROUROLOGY AND URODYNAMICS (2014)
OnabotulinumtoxinA Injection Therapy in Men With LUTS Due to Primary Bladder-Neck Dysfunction: Objective and Patient-Reported Outcomes
Emilio Sacco et al.
NEUROUROLOGY AND URODYNAMICS (2014)
Neurotrophins in Bladder Function: What Do We Know and Where Do We Go From Here?
Celia Duarte Cruz
NEUROUROLOGY AND URODYNAMICS (2014)
Increased Severity of Inflammation Correlates with Elevated Expression of TRPV1 Nerve Fibers and Nerve Growth Factor on Interstitial Cystitis/Bladder Pain Syndrome
Bo-long Liu et al.
UROLOGIA INTERNATIONALIS (2014)
Ulcerative and Nonulcerative Forms of Bladder Pain Syndrome/Interstitial Cystitis Do Not Differ in Symptom Intensity or Response to Onabotulinum Toxin A
Rui Pinto et al.
UROLOGY (2014)
Botulinum toxin for neuropathic pain and spasticity: an overview
E. Alexandra Brown et al.
PAIN MANAGEMENT (2014)
Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome
Jia-Heng Shie et al.
BJU INTERNATIONAL (2013)
OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium
Valerie M. Collins et al.
BJU INTERNATIONAL (2013)
Efficacy and Safety of Botulinum Toxin A Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Review
Irina Soljanik
DRUGS (2013)
A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia
Michael Marberger et al.
EUROPEAN UROLOGY (2013)
Transsynaptic inhibition of spinal transmission by A2 botulinum toxin
Norio Akaike et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Botulinum Toxin A Detrusor Injections Reduce Postsynaptic Muscular M2, M3, P2X2, and P2X3 Receptors in Children and Adolescents Who Have Neurogenic Detrusor Overactivity: A Single-blind Study
Heinrich Schulte-Baukloh et al.
UROLOGY (2013)
Down Regulation of Vascular Endothelial Growth Factor Is Associated With Decreased Inflammation After Intravesical OnabotulinumtoxinA Injections Combined With Hydrodistention for Patients With Interstitial Cystitis-Clinical Results and Immunohistochemistry Analysis
Chung-Hsin Peng et al.
UROLOGY (2013)
Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates
Ali Hamidi Madani et al.
WORLD JOURNAL OF UROLOGY (2013)
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study
Emilio Sacco et al.
BJU INTERNATIONAL (2012)
Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain
J. Oliver Dolly et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder
Youko Ikeda et al.
EUROPEAN UROLOGY (2012)
Pathophysiology of overactive bladder
Mai A. Banakhar et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2012)
Increased Urine and Serum Nerve Growth Factor Levels in Interstitial Cystitis Suggest Chronic Inflammation Is Involved in the Pathogenesis of Disease
Hsin-Tzu Liu et al.
PLOS ONE (2012)
Differences in Mast Cell Infiltration, E-cadherin, and Zonula Occludens-1 Expression Between Patients With Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome
Hsin-Tzu Liu et al.
UROLOGY (2012)
Urodynamic Effects of Transrectal Intraprostatic Ona botulinum Toxin A Injections for Symptomatic Benign Prostatic Hyperplasia
Laetitia M. O. de Kort et al.
UROLOGY (2012)
Symptom-based diagnosis of overactive bladder: an overview
Alan Wein
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2011)
Dysfunctional voiding: A review of the terminology, presentation, evaluation and management in children and adults
Sanjay Sinha
INDIAN JOURNAL OF UROLOGY (2011)
Excitatory Cholinergic and Purinergic Signaling in Bladder Are Equally Susceptible to Botulinum Neurotoxin A Consistent with Co-Release of Transmitters from Efferent Fibers
Gary W. Lawrence et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Bladder Pain Syndrome International Consultation on Incontinence
Philip Hanno et al.
NEUROUROLOGY AND URODYNAMICS (2010)
Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment
Hsin-Tzu Liu et al.
BJU INTERNATIONAL (2009)
Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat
Joao Silva et al.
EUROPEAN UROLOGY (2009)
Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy
Hann-Chorng Kuo et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2009)
Relief by Botulinum Toxin of Lower Urinary Tract Symptoms Owing to Benign Prostatic Hyperplasia: Early and Long-Term Results
Giuseppe Brisinda et al.
UROLOGY (2009)
Effects of Purified Newly Developed Botulinum Neurotoxin Type A in Rat Prostate
Yasuhiro Nishiyama et al.
UROLOGY (2009)
Changes in Adenosine Triphosphate-stimulated ATP Release Suggest Association Between Cytokine and Purinergic Signaling in Bladder Urothelial Cells
Yan Sun et al.
UROLOGY (2009)
TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective
Massimo Lazzeri et al.
THERAPEUTIC ADVANCES IN UROLOGY (2009)
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation
Alvaro Lucioni et al.
BJU INTERNATIONAL (2008)
EFFECT OF SINGLE BOTULINUM TOXIN A INJECTION TO THE EXTERNAL URETHRAL SPHINCTER FOR TREATING DETRUSOR EXTERNAL SPHINCTER DYSSYNERGIA IN SPINAL CORD INJURY
Sung-Lang Chen et al.
JOURNAL OF REHABILITATION MEDICINE (2008)
Mast cell-derived histamine mediates cystitis pain
Charles N. Rudick et al.
JOURNAL OF UROLOGY (2008)
A role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex dimerization during neurosecretion
Elena Fdez et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
The neural control of micturition
Clare J. Fowler et al.
NATURE REVIEWS NEUROSCIENCE (2008)
The use of botulinum toxin a injection for the management of external sphincter dyssynergia in neurologically normal children
Israel Franco et al.
JOURNAL OF UROLOGY (2007)
The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis
Grannum R. Sant et al.
UROLOGY (2007)
Mechanisms of Disease: involvement of the urothelium in bladder dysfunction
Lori A. Birder et al.
NATURE CLINICAL PRACTICE UROLOGY (2007)
Intravesical botulinum toxin a injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis
Hsin-Tzu Liu et al.
UROLOGY (2007)
Botulinum toxin type A for chronic pain and pelvic floor spasm in women - A randomized controlled trial
Jason A. Abbott et al.
OBSTETRICS AND GYNECOLOGY (2006)
SV2 is the protein receptor for botulinum neurotoxin A
M Dong et al.
SCIENCE (2006)
Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity
A Apostolidis et al.
EUROPEAN UROLOGY (2006)
Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder
DE Rapp et al.
JOURNAL OF UROLOGY (2006)
Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction
HC Kuo
UROLOGY (2005)
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity
A Apostolidis et al.
JOURNAL OF UROLOGY (2005)
Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin
A Apostolidis et al.
UROLOGY (2005)
Botulinum toxin: Mechanisms of action
D Dressler et al.
EUROPEAN NEUROLOGY (2005)
Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury
M Khera et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains
G Franciosa et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Urinary bladder contraction and relaxation: Physiology and pathophysiology
KE Andersson et al.
PHYSIOLOGICAL REVIEWS (2004)
Botulinum toxin A has antinociceptive effects in treating interstitial cystitis
CP Smith et al.
UROLOGY (2004)
The role of substance P in inflammatory disease
TM O'Connor et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Up-regulation of P2X(3) receptor during stretch of bladder urothelial cells from patients with interstitial cystitis
Y Sun et al.
JOURNAL OF UROLOGY (2004)
Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract
CP Smith et al.
JOURNAL OF UROLOGY (2003)
CNS involvement in overactive bladder - Pathophysiology and opportunities for pharmacological intervention
KE Andersson et al.
DRUGS (2003)
The standardisation of terminology of lower urinary tract function: Report from the of the International Standardisation Sub-Committee Continence Society
P Abrams et al.
NEUROUROLOGY AND URODYNAMICS (2002)
Learned voiding dysfunction (non-neurogenic, neurogenic bladder) among adults
A Groutz et al.
NEUROUROLOGY AND URODYNAMICS (2001)
Intimate details of the most poisonous poison
BR Singh
NATURE STRUCTURAL BIOLOGY (2000)
Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results
B Schurch et al.
JOURNAL OF UROLOGY (2000)
Share Paper
